A Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Subjects with Sickle Cell Disease
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
May 17, 2017
End Date
September 25, 2020
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
May 17, 2017
End Date
September 25, 2020